Grifols reported EUR5.73B in Current Assets for its fiscal quarter ending in December of 2024.


Current Assets Change Date
Alaunos Therapeutics USD 2.76M 795K Dec/2024
GlaxoSmithKline GBP 17.67B 412M Jun/2025
Grifols EUR 5.73B 404.28M Dec/2024
Life Technologies USD 87.49M 5.54M Jun/2025